You’ve likely heard about CAR-T but do you know what it is and what it means for those living with rare neuroimmune disorders?
Join us on June 17th at 5:00 PM EST for an informative and patient-friendly webinar featuring Dr. Michael Levy and Dr. Marcela Maus, experts from Massachusetts General Hospital/Harvard Medical School, who will break down this complex treatment approach in a way that’s easy to understand. During this time, our expert speakers will educate our live audience about what CAR-T is, how it works and why researchers are hopeful about its potential in conditions like NMOSD, MOGAD, and beyond.
Whether you’re newly diagnosed, living with a condition, or supporting a loved one, this session is designed to empower you with knowledge, clarity and hope for the future of this breakthrough treatment.
Attendees who join live will also have the opportunity to ask questions directly to the experts during the Q&A portion. This webinar will be recorded and made available for replay on TSF’s YouTube channel.
This program was made possible with support from Amgen.
